About this raise
Akttyva Therapeutics, with a valuation of $10 million, is testing the waters on Fundify. It is a biotechnology company working on developing a cure for Acute Respiratory Distress Syndrome (ARDS). ARDS is the common cause of death in pneumonia, flu, and COVID-19; thus, by finding the cure for ARDS, Akttyva Therapeutics aims to convert COVID-19 to the common cold. The first product of Akttyva Therapeutics, AKT-001, is in human safety Phase 1 trial and is patent protected. Katya Tsaioun and Lana Gladstein founded Akttyva Therapeutics in October 2020. The current crowdfunding campaign has a minimum target of $25,000 and a maximum target of $1,000,000. The campaign proceeds will be used for clinical trials.
Investment Overview
Invested : $27,750
Deal Terms
Total Commitments
- Platform
- Fundify
- Start Date
- 03/02/2022
- Close Date
- 03/12/2022
$100
SAFE
Early Stage
Test the Waters
$10,000,000
0%
Company & Team
Company
- Year Founded
- 2020
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Location
- Eastham, Massachusetts
- Company Website
-
Visit Website
Team
Financials
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Company Funding & Growth
Funding history
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 07/31/2022 | Fundify | $10,000,000 | $700 | SAFE | Not Funded | RegCF |
| 03/12/2022 | Fundify | $10,000,000 | $27,750 | SAFE | Funded | Test the Waters |